Barzolvolimab

Customer Review

Based on 1 Customer Validation

Barzolvolimab contains L234A/L235Q/K322Q mutations to silence Fc effector function and introduces M252Y/S254T/T256E mutations to extend its half-life. Barzolvolimab (WT IgG1) (HY-P99462) is a humanized anti-KIT IgG1 monoclonal antibody that retains the natural wild-type Fc and possesses complete antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) effector functions.

For research use only. We do not sell to patients.

  • Purity : 99%
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00